Perrigo Co. has received approval from the Food and Drug Administration for clindamycin phosphate and benzoyl peroxide 1.2%/5% topical gel, a treatment for acne. The company said Wednesday that it has begun shipment of the product, the generic equivalent of Stiefel’s Duac Gel.
CVS/pharmacy has revamped its year-old Beauty Board, a panel of beauty experts who provide interactive content and advice for fans of the CVS Beauty Club Facebook page.
The National Association of Chain Drug Stores has sent a memo to members that gives the upshot of the Supreme Court’s complex ruling on the health care reform law. In the letter to members on Thursday, Don Bell, senior vice president of legal affairs and general counsel for NACDS noted that the
Orabrush said its patented tongue cleaner and tongue foam are now being carried in about 5,000 Walgreens drug stores across the country. The company said Wednesday that the distribution with Walgreens brings the total number of retail outlets carrying Orabrush products to almost 30,000 worldwide.
DC Brands International Inc. has enlisted a national sales and brokerage company to help it broaden distribution of its HARD Nutrition functional water systems and supplements to local and national retailers across multiple channels.
Empowered Products Inc., which offers the PINK and Gun-Oil sexual wellness brands, said sales have escalated since its products shipped to leading chain drug retailers earlier this year.
Nutress Hair Products are now available at select Walgreens drug stores nationwide. Nutress said Tuesday that the five most popular offerings in its product line are on shelves in 400 Walgreens stores.
Stephen Gold is slated to join CVS Caremark Corp. early next month as the new chief information officer. CVS Caremark said Wednesday that Gold, previously CIO of business communications technology provider Avaya Inc., is scheduled to start in the post on July 9.
After hearing the first oral arguments in late March, the U.S. Supreme Court on Thursday upheld the Affordable Care Act (ACA) of 2010, the health care reform law championed by the Obama administration.
The business model that has long sustained the research-based pharmaceutical industry is faltering, with the steady stream of blockbuster medications that once characterized it drying up and competition from generics suppliers increasing as an unprecedented number of branded products lose patent pro
GlaxoSmithKline is changing the way it operates, both internally and in terms of how it interacts with other health care stakeholders.
Part of the solution to the problems of access and cost that beset the nation’s health care system can be found in greater use of over-the-counter medications, an insight on which GlaxoSmithKline Consumer Healthcare is acting.
New products are the lifeblood of the consumer products business, and that’s as true in the over-the-counter drug category as in any other sector.
Divine Skin Inc. has been granted a Drug Enforcement Agency license in tandem with its manufacturing partner to produce and distribute and other controlled substances.
One of the first big drug makers to hit the so-called patent cliff, GlaxoSmithKline (GSK), has responded to a changing industry business model by rethinking its strategic positioning and adopting a more balanced approach to the evolving health care marketplace.
Walgreen Co. is participating in a Centers for Disease Control and Prevention (CDC) pilot through which it will offer free HIV testing.
